neurotrop
murin
coronaviru
mhvjhm
jhmv
caus
enceph
paralyticdemyelin
diseas
suscept
strain
mice
rat
serv
model
human
demyelin
diseas
multipl
sclerosi
commun
report
singl
intracerebr
administr
natur
occur
neuropeptid
flendorphin
reduc
incid
jhmvinduc
paralyticdemyelin
diseas
mice
protect
diseas
accompani
significantli
reduc
viru
replic
brain
earli
day
postinfect
occur
irradi
immunoincompet
mice
data
suggest
flendorphin
engag
immun
mechan
host
resist
jhmv
infect
protect
mice
diseas
neurotrop
strain
mous
hepat
viru
known
jhmv
caus
acut
enceph
accompani
acut
case
chronic
paralyticdemyelin
diseas
suscept
strain
mice
rat
cheever
et
al
weiner
lampert
et
al
sorensen
et
al
knobler
et
al
wege
et
al
dal
canto
rabinowitz
buchmeier
et
al
use
extens
investig
mechan
respons
virusinduc
demyelin
serv
model
human
demyelin
diseas
multipl
sclerosi
ms
jhmvinduc
diseas
evid
indic
oligodendrocyt
death
weiner
lampert
et
al
andor
immunemedi
damag
myelin
sheath
wang
et
al
contribut
demyelin
lesion
depend
viral
strain
age
genet
backgound
mous
rat
host
studi
mhvinduc
neurolog
diseas
facilit
use
variant
mutant
viru
correspond
author
strain
specif
genet
chang
associ
alter
encephalitogen
demyelin
potenti
haspel
et
al
knobler
et
al
koolen
et
al
lamonica
et
al
one
jhmv
mutant
virus
studi
detail
neutralizationresist
strain
select
use
monoclon
antibodi
specif
spike
glycoprotein
jhmv
fleme
et
al
fleme
et
al
clinic
histopatholog
cours
infect
first
week
follow
ic
inocul
extens
character
laboratori
wang
et
al
briefli
viru
grow
rapidli
first
detect
day
pi
reach
peak
clay
signific
drop
infecti
viru
titer
occur
day
continu
declin
undetect
level
day
pi
clinic
sign
infect
first
appar
day
consist
mild
hindlimb
paralysi
usual
becom
sever
day
diseas
either
stabil
recoveri
begin
demyelin
lesion
detect
brain
spinal
cord
earlier
day
characterist
infiltr
mononuclear
cell
first
occur
day
peak
day
time
mononuclear
cell
infiltr
drop
viru
titer
day
pi
suggest
viru
clear
cn
immunemedi
mechan
fact
critic
role
immun
respons
viru
clearanc
protect
death
demonstr
previou
studi
use
sever
addit
jhmv
strain
sussman
et
al
williamson
stohlman
howev
infect
evid
subsequ
demyelin
due
immun
cell
activ
cn
wang
et
al
similar
dual
role
immun
respons
report
cn
diseas
induc
jhmv
rat
wege
et
al
zimprich
et
al
theiler
murin
encephalomyel
viru
tmev
mice
lipton
model
immun
respons
appear
play
initi
protect
role
acut
stage
infect
becom
destruct
later
chronic
stage
commun
address
possibl
natur
occur
immunomodulatori
opioid
peptid
alter
cours
paralyticdemyelin
diseas
origin
rational
studi
base
find
enhanc
mitogenand
antigenstimul
murin
cell
activ
vitro
gilman
et
al
weiner
report
dramat
increas
sever
cn
diseas
swiss
outbr
balbc
mice
infect
temperaturesensit
mutant
vesicular
stomat
viru
vsv
doll
johnson
manner
depend
intact
immun
respons
doll
johnson
hummer
et
al
coon
et
al
dual
role
immun
respons
play
cn
diseas
suggest
administr
would
either
protect
mice
exacerb
diseas
fact
studi
show
singl
ic
inject
time
infect
protect
mice
clinic
histopatholog
diseas
accompani
significantli
reduc
titer
infecti
viru
brain
treat
mice
earli
day
pi
addit
data
suggest
protect
due
control
earli
viru
replic
requir
intact
host
immun
respons
male
mice
purchas
jackson
laboratori
bar
harbor
week
age
allow
adapt
vivarium
condit
day
prior
use
experi
antigen
jhmv
variant
propag
monolay
murin
astrocytoma
dbt
serumfre
condit
presenc
neutral
monoclon
antibodi
recogn
envelop
glycoprotein
jhmv
fleme
et
al
fleme
et
al
larg
plaqu
morpholog
variant
jhmv
known
jhmvdl
stohlman
et
al
also
grown
dbt
monolay
absenc
antibodi
viru
activ
measur
plaqu
assay
dbt
cell
previous
describ
stohlman
weiner
isol
viru
cn
infect
mice
accomplish
report
fleme
et
al
briefli
brain
remov
mice
kill
anesthet
overdos
homogen
use
tenbroeck
homogen
subject
lowspe
centrifug
remov
cell
debri
nuclei
supernat
immedi
appli
dbt
monolay
plaqu
assay
total
volum
xl
viru
pfu
combin
vari
concentr
peptid
inject
parenchyma
right
frontal
lobe
mm
surfac
skull
use
needl
mice
lightli
anesthet
methoxyfluran
metaphan
pitmanmoor
washington
cross
nj
human
nacetyl
endorphin
purchas
peninsula
laboratori
belmont
ca
determin
influenc
immun
function
diseas
cours
infect
mice
wholebodi
gamma
irradi
sourc
appli
rad
per
mous
h
prior
ic
inject
anim
monitor
daili
clinic
sign
viru
infect
blind
fashion
assign
clinic
score
report
wang
et
al
accord
follow
criteria
normal
sign
diseas
slow
right
reflex
accompani
minim
gait
abnorm
sever
gait
abnorm
moder
paraparesi
sever
paraparesi
bilater
hindlimb
paralysi
paraplegia
without
front
limb
involv
observ
continu
sacrific
day
pi
blood
obtain
serolog
confirm
viru
infect
enzymelink
immunosorb
assay
elisa
spinal
cord
remov
histolog
studi
tissu
obtain
sacrific
fix
immers
clark
solut
absolut
glacial
acet
acid
h
prior
routin
process
paraffin
embed
section
xm
routin
stain
hematoxylin
eosin
h
e
experi
myelin
compon
stain
use
luxol
fast
blue
lfb
accord
wang
et
al
identifi
cell
infect
viru
deparaffin
section
tissu
subject
avidinbiotin
immunoperoxidas
procedur
vectastain
vector
laboratori
burlingam
ca
primari
antibodi
monoclon
antibodi
specif
jhmv
nucleocapsid
protein
design
fleme
et
al
infiltr
mononuclear
cell
identifi
use
antibodi
recogn
atcc
tib
hybridoma
mous
isoform
human
common
leukocyt
antigen
recogn
bone
marrowderiv
cell
monoclon
antibodi
use
form
tissu
cultur
supernat
concentr
fig
section
lightli
counterstain
hematoxylin
statist
signific
differ
clinic
score
viru
titer
analys
untreat
group
use
mannwhitney
test
nonparametr
sampl
differ
consid
signific
p
determin
effect
flendorphin
clinic
diseas
induc
male
mice
receiv
singl
ic
inject
pfu
viru
dilut
pb
presenc
absenc
g
mice
observ
daili
sign
neurolog
diseas
day
pi
data
summar
eight
individu
experi
tabl
show
overal
incid
paralysi
reduc
approxim
flendorphintr
mice
thu
mice
inject
flendorphin
exhibit
sign
clinic
diseas
mice
c
clinic
score
determin
day
pi
paralysi
follow
normal
minim
abnorm
andor
slow
right
reflex
mild
hindlimb
paralysi
paralysi
paraplegia
sever
paralysi
associ
wast
statist
signific
differ
treat
untreat
mice
indic
underlin
score
p
mannwhitney
rank
sum
test
nonparametr
sampl
compar
incid
untreat
infect
mice
viru
infect
confirm
mice
includ
treat
flendorphin
presenc
jhmvspecif
antibodi
serum
prepar
blood
obtain
sacrific
measur
elisa
data
shown
protect
effect
flendorphin
rel
proteaseresist
analog
dalazflendorphin
dramat
reflect
clinic
score
assign
blind
fashion
infect
mice
illustr
tabl
exampl
paralysi
score
given
untreat
infect
mice
day
pi
tabl
group
compar
score
treatment
group
group
p
data
present
tabl
overal
incid
diseas
mice
treat
either
peptid
thu
mice
diseas
clinic
score
indic
remain
symptomat
mice
partial
protect
addit
data
suggest
cours
diseas
shorten
mice
reach
earli
peak
day
pi
follow
almost
complet
recoveri
day
pi
untreat
mice
show
increas
paralysi
sever
day
pi
variabl
recoveri
next
month
fleme
et
al
final
statist
signific
differ
clinic
score
mice
receiv
flendorphin
experi
illustr
two
addit
experi
perform
data
shown
although
clinic
score
tend
lower
follow
administr
latter
thu
unless
otherwis
indic
dala
use
subsequ
experi
sake
simplic
refer
flendorphin
throughout
remaind
report
overal
clear
flendorphintr
mice
histolog
studi
spinal
cord
brain
obtain
sacrific
day
pi
reveal
reduc
incid
sever
clinic
diseas
reflect
histopatholog
featur
demyelin
fig
demyelin
lesion
promin
featur
spinal
cord
mice
receiv
treatment
exhibit
myelin
loss
axon
spare
extracellular
vacuolar
chang
typic
infect
lesion
usual
intens
focal
fig
rel
widespread
spinal
cord
white
matter
contrast
spinal
cord
mice
either
show
mild
focal
demyelin
lesion
lesion
fig
anim
clinic
paralysi
show
histolog
lesion
regardless
treatment
statu
overal
data
suggest
protect
clinic
diseas
larg
though
exclus
reflect
protect
demyelin
immunohistochem
studi
show
viru
antigen
present
spinal
cord
obtain
day
pi
control
fig
fig
mice
indic
viru
complet
clear
cn
follow
adminstr
howev
frequent
observ
stain
viru
antigen
intens
wide
distribut
spinal
cord
untreat
mice
fig
rel
treat
mice
fig
infiltr
bear
cell
readili
detect
day
pi
spinal
cord
fig
f
brain
data
shown
treatment
group
mani
biolog
activ
opioid
peptid
depend
upon
share
ntermin
opioid
core
amino
acid
sequenc
tyrglyglyphemet
leu
modif
core
structur
acetyl
interfer
peptid
bind
opioid
receptor
abolish
analges
activ
deakin
et
al
similarli
infect
substitut
nacflendorphin
nativ
peptid
result
protect
paralyticdemyelin
diseas
tabl
data
suggest
nterminu
perhap
opioid
receptor
requir
protect
effect
tabl
also
indic
protect
observ
singl
dose
low
gmous
addit
doserespons
studi
shown
protec
tion
consist
observ
concentr
gmous
lower
data
shown
one
possibl
mean
flendorphin
may
protect
mice
cn
diseas
effect
jhmv
growth
cn
test
experi
clarifi
supernat
prepar
brain
untreat
mice
day
pi
test
viral
activ
plaqu
assay
illustr
fig
viru
growth
significantli
reduc
brain
mice
earli
day
pi
remain
reduc
throughout
period
test
differ
treat
untreat
mice
statist
signific
day
pi
p
time
point
flendorphintr
mice
viru
titer
less
z
pfu
brain
tissu
remain
show
titer
pfu
data
shown
variabl
individu
valu
obtain
day
pi
viru
growth
declin
untreat
mice
fig
fleme
et
al
result
lack
statist
signific
differ
two
group
data
suggest
treatment
prevent
establish
product
infect
throughout
cours
diseas
sinc
basic
peptid
possibl
reduct
day
viru
titer
may
due
nonspecif
peptideviru
interact
prevent
infect
viru
growth
test
vitro
plaqu
assay
variou
dilut
viru
ad
dbt
cell
plate
presenc
absenc
high
concentr
gwell
addit
larg
plaqu
morpholog
variant
jhmvdl
also
test
neutral
peptid
plaqu
count
h
pi
result
present
tabl
data
show
concentr
flendorphin
higher
capabl
protect
mice
diseas
prevent
infect
vitro
addit
effect
growth
either
encephalitogen
strain
jhmvdl
less
virul
paralysisinduc
data
suggest
unlik
flendorphin
directli
affect
abil
jhmv
infect
grow
cell
deriv
cn
suggest
facilit
protect
indirectli
effect
host
resist
viru
infect
sinc
clearanc
jhmv
cn
depend
intact
immun
system
sinc
appear
directli
neutral
viru
vitro
reason
hypothes
protect
effect
involv
immun
respons
test
possi
biliti
mice
render
immunoincompet
wholebodi
gamma
irradi
h
prior
jhmv
infect
treatment
tabl
present
data
show
abl
protect
mice
cn
diseas
immun
system
impair
evid
directli
interfer
viru
infect
replic
sinc
irradi
mice
succumb
enceph
spite
treatment
data
provid
evid
immun
system
may
requir
protect
effect
commun
present
data
show
singl
intracerebr
administr
protect
mice
paralyticdemyelin
diseas
induc
neutralizationresist
variant
jhmv
protect
observ
reduc
overal
diseas
incid
markedli
reduc
diseas
sever
partial
protect
reflect
clinic
histolog
evalu
preliminari
data
suggest
opioid
receptor
involv
sinc
substitut
opioidinact
nacetyl
protect
mice
diseas
tabl
administr
flendorphin
associ
significantli
diminish
viru
growth
brain
infect
mice
earli
day
pi
brain
viru
titer
remain
lower
limit
detect
day
pi
viru
growth
decreas
untreat
mice
data
suggest
treatment
prevent
establish
product
infect
cn
find
protect
mice
diseas
differ
consider
report
vsvinduc
diseas
aggress
cn
diseas
occur
administ
h
prior
infect
doll
johnson
hummer
et
al
discrep
may
explain
obviou
differ
type
cn
diseas
two
virus
caus
differ
strain
mice
time
pathogen
event
initi
viru
differ
role
host
respons
play
pathogen
thu
temperaturesensit
strain
vsv
design
ts
vsv
produc
either
clinic
symptom
normal
balbc
mice
slowli
progress
cn
diseas
character
wast
loss
appetit
hindlimb
paralysi
death
balbc
nude
mice
within
day
inocul
addit
temperatur
sensit
ts
vsv
render
capabl
replic
follow
decreas
core
bodi
temperatur
occur
follow
ic
inject
nemeroff
et
al
contrast
jhmv
variant
caus
paralyticdemyelin
diseas
infect
balbc
mice
day
pi
shown
temperatur
sensit
test
growth
unpublish
observ
jhmvinduc
cn
diseas
host
immun
respons
play
dual
role
initi
protect
infiltr
immun
cell
follow
later
destruct
immun
respons
determin
remain
diseas
cours
immun
respons
also
appear
critic
surviv
follow
ts
vsv
infect
sinc
balbc
nude
mice
eventu
succumb
progress
cn
diseas
although
clear
whether
immun
respons
contribut
vsv
pathogenesi
requir
exacerb
effect
suggest
may
differ
flendorphin
influenc
two
model
may
reflect
time
specif
pathogen
event
interestingli
necessari
administ
h
prior
vsv
infect
aggress
diseas
appear
pharmacolog
paramet
protect
effect
particular
model
virusinduc
diseas
current
earli
stage
investig
preliminari
test
opioid
specif
protect
commun
suggest
involv
opioid
receptor
sinc
nacetyl
flendorphin
effect
howev
addit
experi
use
opioid
antagonist
naloxon
naltrexon
necessari
confirm
result
also
observ
protect
essenti
equal
afford
proteas
resist
analog
suggest
rel
effici
initi
event
ultim
lead
reduc
viru
growth
cn
protect
paralyticdemyelin
diseas
addit
pharmacolog
paramet
current
earli
stage
investig
dose
requir
protect
effect
clear
protect
accomplish
concentr
nanomolar
high
physiolog
rang
though
consist
observ
protect
dose
lower
observ
increas
diseas
sever
high
low
dose
exacerb
vsvinduc
cn
diseas
report
occur
concentr
low
pm
hummer
et
al
observ
current
studi
perhap
critic
understand
possibl
mechan
flendorphin
protect
design
futur
studi
dramat
reduct
viru
growth
occur
earliest
pi
time
test
ie
day
pi
least
three
possibl
mechan
viru
replic
may
reduc
cn
day
pi
neutral
viru
nonspecif
peptideviru
interact
ii
activ
intrins
cellular
mechan
resist
iii
initi
nonspecif
immun
respons
capabl
clear
viru
cn
sinc
basic
peptid
possibl
bind
nonspecif
viru
effect
neutral
prevent
infect
seem
unlik
occur
sinc
effect
vitro
viru
yield
even
ad
concentr
ten
time
higher
highest
dose
test
vivo
tabl
addit
flendorphin
abl
protect
mice
death
due
infect
encephalitogen
viru
strain
jhmvdl
unpublish
data
engag
intrins
cellular
mechan
resist
protect
mice
jhmvinduc
diseas
one
might
also
predict
jhmv
growth
would
diminish
vitro
fact
occur
argu
involv
intrins
resist
mechan
protect
howev
studi
need
character
jhmv
growth
presenc
vitro
vivo
identifi
possibl
effect
number
viru
particl
yield
per
cell
number
cell
infect
andor
region
cellular
distribut
viru
infect
tissu
experi
natur
current
plan
possibl
treatment
initi
involv
immun
respons
protect
support
preliminarili
lack
protect
occur
irradi
mice
tabl
sinc
cn
shield
irradi
experi
possibl
abrog
protect
involv
radiosensit
cell
cn
perhap
disturb
bloodbrain
barrier
howev
wang
et
al
appli
shield
differenti
cn
peripheri
order
establish
involv
immun
respons
lesion
format
follow
infect
data
indic
shield
either
cn
system
compart
prior
day
pi
effect
diseas
outcom
although
thu
seem
unlik
irradi
cn
involv
elimin
flendorphin
protect
necessari
repeat
experi
cn
shield
irradi
addit
though
indirect
support
involv
immun
respons
protect
provid
publish
data
concern
influenc
cellular
activ
immun
system
thu
enhanc
inhibit
cell
activ
inhibit
antibodi
product
b
cell
enhanc
cytolyt
activ
natur
killer
nk
cell
modul
sever
function
macrophag
neutrophil
human
rodent
invertebr
vitro
vivo
review
see
sibinga
goldstein
gilmor
et
al
carr
heijnen
et
al
cell
type
shown
infiltr
cn
follow
ic
infect
variou
strain
jhmv
dorri
et
al
williamson
et
al
williamson
well
document
immunocompet
essenti
first
pi
day
control
viru
replic
prevent
death
due
enceph
weiner
sussman
et
al
zimmer
dale
williamson
stohlman
kinet
appear
immun
cell
suggest
earli
immun
respons
brain
nonspecif
involv
nkllbear
nk
cell
macrophag
williamson
et
al
williamson
isol
earli
day
pi
interestingli
vivo
infus
later
cerebr
ventricl
rat
brain
induc
macrophag
monocyt
chemotaxi
ventricl
saland
et
al
vitro
opioid
peptid
stimul
human
lymphocyt
monocyt
motil
chemotaxi
van
epp
saland
ye
et
al
sacerdot
panerai
heagi
et
al
increas
human
neutrophil
adher
serumco
glass
van
epp
kutvirt
enhanc
secret
mous
bone
marrowderiv
ceil
apt
et
al
stimul
gamma
interferon
ifni
secret
human
mononuclear
cell
brown
van
epp
sinc
intracerebr
inject
ifni
result
migrat
inflammatori
cell
rat
brain
within
h
sethna
lampson
may
also
act
indirectli
recruit
earli
immun
respons
clear
jhmv
brain
seem
unlik
antivir
antibodi
play
role
protect
primarili
earliest
detect
antibodi
respons
follow
jhmv
infect
occur
day
pi
minim
igm
concentr
xg
less
maxim
igm
titer
zg
occur
day
pi
igg
detect
first
day
pi
thu
unlik
antibodi
account
reduct
viru
growth
day
pi
follow
administr
addit
detect
differ
antibodi
titer
untreat
mice
day
pi
serum
test
confirm
viru
infect
data
shown
final
clearli
shown
inhibitori
effect
antibodi
product
rodent
review
sibinga
goldstein
gilmor
et
al
carr
heijnen
et
al
sinc
viru
growth
also
restrict
least
day
pi
fig
possibl
may
influenc
function
antigenspecif
nonspecif
immun
cell
enter
cn
later
stage
infect
must
consid
possibl
gain
credibl
view
fact
day
pi
cell
capabl
prolifer
secret
ifni
respons
jhmv
begin
second
antigenspecif
wave
defens
viru
williamson
et
al
williamson
addit
preliminari
data
laboratori
indic
jhmvspecif
cell
prolifer
enhanc
lymphocyt
isol
cervic
lymph
node
infect
mice
compar
respons
cell
isol
untreat
control
mice
data
shown
thu
singl
ic
administr
flendorphin
capabl
signific
influenc
later
immun
activ
view
find
sinc
paralyticdemyelin
diseas
induc
jhmv
variant
depend
presenc
cell
special
interest
determin
whether
delay
administr
least
day
follow
jhmv
infect
result
exacerb
diseas
ultim
may
possibl
manipul
specif
stage
diseas
predict
fashion
also
design
success
strategi
treatment
immunemedi
cn
diseas
